316 related articles for article (PubMed ID: 11033476)
1. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
[TBL] [Abstract][Full Text] [Related]
2. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?
Sopeña B; Pérez-Rodríguez MT; Rivera A; Ortiz-Rey JA; Lamas J; Freire-Dapena MC
Lupus; 2010 Oct; 19(11):1340-3. PubMed ID: 20659971
[TBL] [Abstract][Full Text] [Related]
3. A case of livedoid vasculopathy in a 22-year-old man.
Leonard A; Pomeranz MK; Franks AG
J Drugs Dermatol; 2004; 3(6):678-9. PubMed ID: 15624752
[TBL] [Abstract][Full Text] [Related]
4. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
Browning CE; Callen JP
Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
[TBL] [Abstract][Full Text] [Related]
5. [Vasculitis and vasculopathy].
Marković A
Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
[TBL] [Abstract][Full Text] [Related]
6. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
[TBL] [Abstract][Full Text] [Related]
7. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?
Acland KM; Darvay A; Wakelin SH; Russell-Jones R
Br J Dermatol; 1999 Jan; 140(1):131-5. PubMed ID: 10215783
[TBL] [Abstract][Full Text] [Related]
8. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
[TBL] [Abstract][Full Text] [Related]
9. Livedoid vasculopathy: further evidence for procoagulant pathogenesis.
Hairston BR; Davis MD; Pittelkow MR; Ahmed I
Arch Dermatol; 2006 Nov; 142(11):1413-8. PubMed ID: 17116831
[TBL] [Abstract][Full Text] [Related]
10. [Livedoid vasculitis in a patient with antiphospholipid syndrome].
Serra S; Saavedra MJ; Salvador MJ; Reis JP; Malcata A
Acta Reumatol Port; 2010; 35(2):249-53. PubMed ID: 20711098
[TBL] [Abstract][Full Text] [Related]
11. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
[TBL] [Abstract][Full Text] [Related]
12. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
Cardoso R; Gonçalo M; Tellechea O; Maia R; Borges C; Silva JA; Figueiredo A
Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous manifestations of antiphospholipid antibody syndrome.
Weinstein S; Piette W
Hematol Oncol Clin North Am; 2008 Feb; 22(1):67-77, vi. PubMed ID: 18207066
[TBL] [Abstract][Full Text] [Related]
14. ["Idiopathic" white atrophy].
Tran MD; Bécherel PA; Cordel N; Piette JC; Francès C
Ann Dermatol Venereol; 2001 Oct; 128(10 Pt 1):1003-7. PubMed ID: 11907958
[TBL] [Abstract][Full Text] [Related]
15. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin].
Becker A; Stoffels-Weindorf M; Schimming T; Dissemond J
Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447
[TBL] [Abstract][Full Text] [Related]
16. Livedoid vasculopathy: A review of pathogenesis and principles of management.
Vasudevan B; Neema S; Verma R
Indian J Dermatol Venereol Leprol; 2016; 82(5):478-88. PubMed ID: 27297279
[TBL] [Abstract][Full Text] [Related]
17. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study.
Di Giacomo TB; Hussein TP; Souza DG; Criado PR
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1340-6. PubMed ID: 20337814
[TBL] [Abstract][Full Text] [Related]
18. [Antiphospholipid antibody syndrome as the cause of clinical rapidly progressing vasculopathy].
Henning BF; Büchner N; Kirchner J; Gillessen A
Dtsch Med Wochenschr; 2000 May; 125(19):589-93. PubMed ID: 11320717
[TBL] [Abstract][Full Text] [Related]
19. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
[TBL] [Abstract][Full Text] [Related]
20. Livedoid vasculopathy associated with heterozygous protein C deficiency.
Boyvat A; Kundakçi N; Babikir MO; Gürgey E
Br J Dermatol; 2000 Oct; 143(4):840-2. PubMed ID: 11069468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
